Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-27T12:30:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the safety and efficacy of pembrolizumab in treating renal cell carcinoma, while adding identifiers and a new revision number.
    Difference
    16%
    Check dated 2025-04-20T06:38:18.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-05T17:11:33.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.14.3, replacing the previous version 2.14.2.
    Difference
    0.0%
    Check dated 2025-03-29T13:25:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-20T11:54:04.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.
    Difference
    0.5%
    Check dated 2025-02-06T06:41:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.